These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10741546)

  • 41. Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazoline-2,4-diones as glycine-NMDA antagonists: a pharmacophore model based approach.
    Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
    Arch Pharm (Weinheim); 1997 May; 330(5):129-34. PubMed ID: 9237424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
    Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
    J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ
    Thum S; Schepmann D; Ayet E; Pujol M; Nieto FR; Ametamey SM; Wünsch B
    Eur J Med Chem; 2019 Sep; 177():47-62. PubMed ID: 31129453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.
    Nguyen KT; Claiborne CF; McCauley JA; Libby BE; Claremon DA; Bednar RA; Mosser SD; Gaul SL; Connolly TM; Condra CL; Bednar B; Stump GL; Lynch JJ; Koblan KS; Liverton NJ
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3997-4000. PubMed ID: 17498948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
    Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
    J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices.
    Mallon AP; Auberson YP; Stone TW
    Exp Brain Res; 2005 Apr; 162(3):374-83. PubMed ID: 15580338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of the antiparkinsonian drug budipine on central neurotransmitter systems.
    Klockgether T; Wüllner U; Steinbach JP; Petersen V; Turski L; Löschmann PA
    Eur J Pharmacol; 1996 Apr; 301(1-3):67-73. PubMed ID: 8773448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.
    Truong L; Allbutt HN; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):91-6. PubMed ID: 19007866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ifenprodil and ethanol enhance NMDA receptor-dependent long-term depression.
    Hendricson AW; Miao CL; Lippmann MJ; Morrisett RA
    J Pharmacol Exp Ther; 2002 Jun; 301(3):938-44. PubMed ID: 12023522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and synthesis of a novel water-soluble NMDA receptor antagonist with a 1,4,7,10-tetraazacyclododecane group.
    Masuko T; Metori K; Kizawa Y; Kusama T; Miyake M
    Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):444-7. PubMed ID: 15802850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes.
    Pahk AJ; Williams K
    Neurosci Lett; 1997 Mar; 225(1):29-32. PubMed ID: 9143010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J; Rajakumar N
    Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Azagrevellins, Part I. Grevellin analogs with affinity to the N-methyl-D-aspartate (glycine site) receptor, a novel lead structure.
    Poschenrieder H; Höfner G; Stachel HD
    Arch Pharm (Weinheim); 2000 Jul; 333(7):211-6. PubMed ID: 10965595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives.
    Fray MJ; Bull DJ; Carr CL; Gautier EC; Mowbray CE; Stobie A
    J Med Chem; 2001 Jun; 44(12):1951-62. PubMed ID: 11384240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis, and biological evaluation of tricyclic heterocycle-tetraamine conjugates as potent NMDA channel blockers.
    Takayama H; Yaegashi Y; Kitajima M; Han X; Nishimura K; Okuyama S; Igarashi K
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4729-32. PubMed ID: 17624774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 1-Benzyloxy-4,5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists.
    Alanine A; Bourson A; Büttelmann B; Gill R; Heitz MP; Mutel V; Pinard E; Trube G; Wyler R
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3155-9. PubMed ID: 12951084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissociable effects of NR2A and NR2B NMDA receptor antagonism on cognitive flexibility but not pattern separation.
    Kumar G; Olley J; Steckler T; Talpos J
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3991-4003. PubMed ID: 26184010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.